Brian Dimarco Email & Phone Number
Who is Brian Dimarco? Overview
A concise factual answer block for searchers comparing this professional profile.
Brian Dimarco is listed as Biotech/Pharma Sales & Marketing Professional | Experienced Launch Marketer | Brand Leadership | Rare Diseases | MBA at Sobi - Swedish Orphan Biovitrum AB (publ), a company with 1087 employees, based in Greater Boston, United States, United States. AeroLeads shows a matched LinkedIn profile for Brian Dimarco.
Brian Dimarco previously worked as Director, US Marketing at Sobi - Swedish Orphan Biovitrum Ab (Publ) and Director, US Franchise Strategy at Alnylam Pharmaceuticals. Brian Dimarco holds Master Of Business Administration (M.B.A.), Health Sector Management from Boston University.
Email format at Sobi - Swedish Orphan Biovitrum AB (publ)
This section adds company-level context without repeating Brian Dimarco's masked contact details.
Review company-level records connected to Brian Dimarco before choosing the right outreach path.
About Brian Dimarco
Results-driven, collaborative, team-oriented marketing and sales professional with 12+ years of combined marketing, sales, strategy, and field training experience. Extensive brand team experience and leadership within pre-launch and launch, growth, and cornerstone brands in highly competitive markets spanning ultra-rare to prevalent diseases. This experience includes contributing to large and midsize pharmaceutical companies, as well as small biotech startups. Successfully helped grow organizations, launch brands, and set strategic franchise vision while inspiring people and developing a high-energy and positive culture in a variety of business environments, including co-promotion. My key strengths include:► Brand Strategy
Brian Dimarco's current company
Company context helps verify the profile and gives searchers a useful next step.
Brian Dimarco work experience
A career timeline built from the work history available for this profile.
Director, Us Franchise Strategy
- Led development of US strategic vision and plans to increase disease awareness of rare disease, supporting market leadership and product differentiation for Amvuttra® (vutrisiran) and Onpattro® (patisiran)
- Developed and led launch readiness efforts as US launch lead, managing a cross-functional launch team, defining launch performance KPIs, presenting launch strategy and process to executive leadership, and facilitating.
- Partnered with global marketing team to ensure global launch strategy accounted for US market specificities, preparing organization for first launch into a competitive, prevalent cardiovascular market
- Served as core member of the US marketing team, leading franchise strategy to align all marketing initiatives with overall franchise goals through close partnership with HCP and patient marketing teams
- Supported development and facilitation of competitive readiness exercises, preparing organization for various future scenarios, including increased competition, evolving payer landscape, generic entrants, and future.
Senior Director, Marketing
- Supported preparation of second indication US launch strategy for Bylvay® (odevixibat) with HCP tactical planning, building and executing full HCP marketing mix to drive brand growth and portfolio development
- Led development and design of franchise portfolio—both branded and unbranded—supporting field force efforts through disease state education and awareness, peer-to-peer education, non-personal promotion, advisory.
- Directed internal plan-of-action (POA) meetings and annual brand planning efforts for US region
- Drove expansion of US HCP targeting and developed HCP adoption and brand advocacy targeting framework
- Oversaw budget process, achieving overall expense forecast accuracy each year
- Managed and supported development of marketing product manager
Director, Global Marketing
- Led development of US and global brand strategies and HCP marketing tactical plans by assimilating input from across functions and regions to build the organization’s first commercial launch plan in rare diseases
- Headed global commercial launch team, ensuring launch preparations remained on track and opportunities and issues were identified and addressed across functions and regions with clear communication
- Built promotional platform, including brand messaging and creative campaign, along with a full range of omnichannel marketing programs and materials that drove competitive differentiation and patient identification.
- Developed commercial plans, in collaboration with medical affairs, to lead and execute a comprehensive KOL engagement plan, global steering committee, speaker bureau, and presence at key medical congresses in the US.
- Hired, managed, and developed product manager that supported the execution of annual tactical plans
- Partnered with commercial analytics to ensure planning and execution of all market research projects
Associate Director, Marketing
- Market Development
- Led overall execution of branded and unbranded speaker bureau - including content approval, speaker credentialing, training, utilization, and a metrics assessment - in a co-promote environment (Regeneron)
- Supported development, execution, and evaluation of strategic marketing tactics associated with medical congresses and field-based thought leader liaisons (TLLs) in line with the life cycle management plan
- Interfaced with national thought leaders to deliver differentiated disease state education resources to support market development objectives for immunology specialists within allergy, pulmonary, and ENT
- Collaborated with sales, medical affairs, legal, and regulatory to ensure cross-functional alignment and execution of key priorities and served as the team champion to process and lead projects through the Regulatory.
- Recipient of the 2019 Individual Collaboration Award
Senior Product Manager
- HCP Marketing
- Executed brand strategy through all field force initiatives for launch brand Dupixent® (dupilumab) in a highly competitive, prevalent biologics market within the immunology space targeting allergist and pulmonologists
- Led business planning and execution efforts across a complex alliance environment through a multiple phased business planning initiative across all functions, to ensure teams were set up for success and allowed.
- Organized and led consistent communication touch points across all levels of sales to ensure a successful execution of all launch planning priorities and tactics, as well as sales training to best prepare the field to.
- Optimized launch efforts by leading the planning and execution of pre-launch meetings, including serving as brand lead for strategic vision, meeting objectives, and agenda for a national pre-PDUFA launch meeting
- Supported development of Day 1/Launch HCP materials across the alliance and led the process to push them live to ensure the sales force had all appropriate resources (print and digital) to execute the business plans
Product Manager
- Portfolio Marketing
- Supported strategic design of franchise portfolio - Firazyr® (icatibant injection), CINRYZE® (C1 esterase inhibitor [human]), and Kalbitor® (ecallantide) - and led execution of HCP and patient tactics across all.
- Supported HCP strategy and led tactical execution and management of all HCP assets and lead-generating initiatives, including conferences, national Pri-Med events, and regional Medical Mystery programs, while serving.
- Supported patient marketing team in execution of the branded strategy and tactics, while leading unbranded efforts by driving disease state awareness through key advocacy, speaker bureau, and social channels
Pharmaceutical Sales Representative
- Growth driver for seven brands within five different disease states across Allergists, ENTs, Pediatricians, and PCPs Awards: Circle of Excellence (Top 20% in Nation) winner for overall sales performanceWinner of the.
Colleagues at Sobi - Swedish Orphan Biovitrum AB (publ)
Other employees you can reach at sobi.com. View company contacts for 1087 employees →
Diana Otero
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)Miami-Fort Lauderdale Area, United States
View →
ES
Elis Sundelin
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)Greater Stockholm Metropolitan Area, Sweden
View →
JL
James Lennon
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)New York City Metropolitan Area, United States
View →
AL
Alexandra Lejeune
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)Basel, Basel, Switzerland, Switzerland
View →
DW
Domenico Wernthaler
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)Krailling, Bavaria, Germany, Germany
View →
TS
Tracy Snyder
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)South Lake Tahoe, California, United States, United States
View →
PN
Phuong Nguyen
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)West Chicago, Illinois, United States, United States
View →
DD
Dominika Danebjer
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)Stockholm, Stockholm County, Sweden, Sweden
View →
SB
Simon Brophy
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)Romford, England, United Kingdom, United Kingdom
View →
LR
Lucija Rus
Colleague at Sobi - Swedish Orphan Biovitrum Ab (Publ)Ljubljana, Ljubljana, Slovenia, Slovenia
View →
Brian Dimarco education
Master Of Business Administration (M.B.A.), Health Sector Management
Bs, Business
Bachelor'S Degree, Business Administration
Frequently asked questions about Brian Dimarco
Quick answers generated from the profile data available on this page.
What company does Brian Dimarco work for?
Brian Dimarco works for Sobi - Swedish Orphan Biovitrum AB (publ).
What is Brian Dimarco's role at Sobi - Swedish Orphan Biovitrum AB (publ)?
Brian Dimarco is listed as Biotech/Pharma Sales & Marketing Professional | Experienced Launch Marketer | Brand Leadership | Rare Diseases | MBA at Sobi - Swedish Orphan Biovitrum AB (publ).
Where is Brian Dimarco based?
Brian Dimarco is based in Greater Boston, United States, United States while working with Sobi - Swedish Orphan Biovitrum AB (publ).
What companies has Brian Dimarco worked for?
Brian Dimarco has worked for Sobi - Swedish Orphan Biovitrum Ab (Publ), Alnylam Pharmaceuticals, Albireo Pharma, Inc. (Acquired By Ipsen), Albireo Pharma, Inc., and Sanofi Genzyme.
Who are Brian Dimarco's colleagues at Sobi - Swedish Orphan Biovitrum AB (publ)?
Brian Dimarco's colleagues at Sobi - Swedish Orphan Biovitrum AB (publ) include Diana Otero, Elis Sundelin, James Lennon, Alexandra Lejeune, and Domenico Wernthaler.
How can I contact Brian Dimarco?
You can use AeroLeads to view verified contact signals for Brian Dimarco at Sobi - Swedish Orphan Biovitrum AB (publ), including work email, phone, and LinkedIn data when available.
What schools did Brian Dimarco attend?
Brian Dimarco holds Master Of Business Administration (M.B.A.), Health Sector Management from Boston University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Brian Dimarco you were looking for.
View similar profiles